A. Goldstone

P. Moss, S. Mackinnon, K. Peggs, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A comparison of low‐dose cytarabine and hydroxyurea with or without all‐trans retinoic acid for acute myeloid leukemia and high‐risk myelodysplastic syndrome in patients not considered fit for intensive treatment

R. Hills, M. McMullin, A. Goldstone, 2007, Cancer.

Autologous stem cell transplantation in Hodgkin's disease.

I. Avivi, A. Goldstone, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

First remission autologous bone marrow transplantation for Hodgkin's disease--preliminary EBMT data.

A. Goldstone, S. Bradley, R. Pearce, 1995, Leukemia & lymphoma.

High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.

N. Schmitz, A. Hunter, C. Kyriakou, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-Dose Therapy and Autologous Stem-Cell Transplantation for Adult Patients With Hodgkin's Disease Who Do Not Enter Remission After Induction Chemotherapy: Results in 175 Patients Reported to the European Group for Blood and Marrow Transplantation

N. Schmitz, R. Marcus, D. Cunningham, 1999 .

Transplantation in adult ALL.

J. Rowe, A. Goldstone, 2009, Hematology. American Society of Hematology. Education Program.

Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses.

S. Mackinnon, K. Peggs, D. Linch, 2004, Blood.

Measurement of haematological indices of chronic rheumatic disease with two newer generation automated systems, the H1 and H6000 (Technicon).

A. Todd-Pokropek, D. Isenberg, L. Turner-Stokes, 1991, Annals of the rheumatic diseases.

Appearance of anti-DNA antibodies in patients treated with interferon-alpha.

D. Isenberg, A. Goldstone, M. Ehrenstein, 1993, Arthritis and rheumatism.

Differentiation Linked Expression of p28,33 (Ia‐like) Structures on Human Leukaemic Cells

M. Greaves, G. Janossy, M. Pippard, 1977, British journal of haematology.

Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantation.

N. Schmitz, C. Kyriakou, G. Kobbe, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Haematological reassessment of rheumatoid arthritis using an automated method.

A. Todd-Pokropek, D. Isenberg, M. Snaith, 1986, British journal of rheumatology.

Autologous stem cell transplantation for follicular lymphoma is of most benefit early in the disease course and can result in durable remissions, irrespective of prior rituximab exposure

K. Ardeshna, K. Peggs, D. Linch, 2014, British journal of haematology.

High response rate to donor lymphocyte infusion after allogeneic stem cell transplantation for indolent non-Hodgkin lymphoma.

S. Mackinnon, K. Peggs, S. Verfuerth, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Conventional second‐line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first‐line salvage therapy regimens

K. Ardeshna, S. Mackinnon, P. Hoskin, 2005, British journal of haematology.

Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data.

R. Chopra, A. Goldstone, T. Philip, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: results in 175 patients reported to the European Group for Blood and Marrow Transplantation. Lymphoma Working Party.

N. Schmitz, R. Marcus, D. Cunningham, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Massive chemotherapy with autologous bone marrow transplantation in 50 cases of bad prognosis non‐Hodgkin's lymphoma

P. Biron, D. Linch, P. Hervé, 1985, British journal of haematology.

Etoposide, methylprednisolone, cytarabine and cisplatin successfully cytoreduces resistant myeloma patients and mobilizes them for transplant without adverse effects

K. Ardeshna, K. Peggs, A. Goldstone, 2004, British journal of haematology.

Treatment of chronic myeloid leukaemia in first chronic phase with idarubicin and cytarabine: mobilization of Philadelphia‐negative peripheral blood stem cells

R. Clark, A. Goldstone, A. Newland, 1997, British journal of haematology.

Acute promyelocytic leukaemia: further evidence of the differentiation-linked expression of Ia-like (p28,33) antigens on leukaemic cells.

G. Janossy, B. Mcverry, A. Goldstone, 2009, Scandinavian journal of haematology.

Redefining Transplant in Acute Leukemia

H. Lazarus, A. Goldstone, R. Sellar, 2011, Current treatment options in oncology.

The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPA.

R. Hills, D. Linch, A. Goldstone, 2010, Blood.

CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Presenting White Blood Cell Count and Kinetics of Molecular Remission Predict Prognosis in Acute Promyelocytic Leukemia Treated With All- Trans Retinoic Acid: Result of the Randomized MRC Trial

D. Grimwade, E. Solomon, A. Goldstone, 2022 .

Conventional allograft and autograft in low grade lymphoma.

I. Avivi, A. Goldstone, 2005, Best practice & research. Clinical haematology.

High-dose therapy and autologous bone marrow transplantation in first complete remission for adult patients with high-grade non-Hodgkin's lymphoma : the EBMT experience

D. Blaise, A. Goldstone, J. Sweetenham, 1994 .

The value of molecular stratification for CEBPA DM and NPM1 MUT FLT3 WT genotypes in older patients with acute myeloid leukaemia

R. Hills, D. Linch, Akbar Ali, 2015, British journal of haematology.

Retinoic Acid: Result of the Randomized MRC Trial All-Trans Predict Prognosis in Acute Promyelocytic Leukemia Treated With Presenting White Blood Cell Count and Kinetics of Molecular Remission

D. Grimwade, E. Solomon, A. Goldstone, 2013 .

D. Grimwade, E. Solomon, A. Goldstone, 2022 .

Curability of patients with acute myeloid leukemia who did not undergo transplantation in first remission.

R. Hills, N. Russell, A. Hunter, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the Randomized MRC Trial.

D. Grimwade, E. Solomon, A. Goldstone, 1999, Blood.

Identification of PML/RARα rearrangements in suspected acute promyelocytic leukemia using fluorescence in situ hybridization of bone marrow smears: a comparison with cytogenetics and RT-PCR in MRC ATRA trial patients

A. Chase, D. Grimwade, A. Goldstone, 2000, Leukemia.

The importance of diagnostic cytogenetics in older patients with AML: Analysis of 922 patients entered into the MRC AML 11 trial.

D. Grimwade, A. Goldstone, A. Burnett, 1999 .

Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT

N. Schmitz, A. Rohatiner, G. Meloni, 1999, British journal of haematology.

Frequency of clonal remission in acute myeloid leukaemia

D. Linch, A. Goldstone, A. Burnett, 1993, The Lancet.

Rituximab purging and/or maintenance in patients undergoing autologous transplantation for relapsed follicular lymphoma: a prospective randomized trial from the lymphoma working party of the European group for blood and marrow transplantation.

E. Kimby, N. Schmitz, H. Tilly, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

SOHO State of the Art Update and Next Questions: Philadelphia Chromosome‐Positive Acute Lymphoblastic Leukemia

C. Pui, H. Kantarjian, E. Jabbour, 2018, Clinical lymphoma, myeloma & leukemia.

lymphoblastic leukemia regimen enhances long-term outcomes in Philadelphia positive acute UKALLXII/ECOG2993: addition of imatinib to a standard treatment

M. Tallman, L. Foroni, G. Gerrard, 2014 .

UKALLXII / ECOG 2993 : addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia

M. Tallman, L. Foroni, G. Gerrard, 2014 .

Attempts to Optimise Induction and Consolidation Chemotherapy in Patients with Acute Myeloid Leukaemia: Results of the MRC AML15 Trial.

R. Hills, N. Russell, L. Kjeldsen, 2009 .

A Sensitive Risk Score for Directing Treatment in Younger Patients with AML.

R. Hills, A. Goldstone, A. Burnett, 2006 .

Non-myeloablative allogeneic transplantation for high-risk acute leukemia and myelodysplasia.

C. Craddock, S. Mackinnon, K. Peggs, 2001 .

Donor Lymphocyte Infusions Induce High Response Rates and Durable Salvage in Relapsed Hodgkin Lymphoma Post T Cell Depleted Allogeneic Transplantation.

K. Ardeshna, S. Mackinnon, K. Peggs, 2009 .

University of An operational definition of primary refractory acute myeloid leukemia allowing early identification of patients who may benefit from allogeneic stem cell transplantation

P. Vyas, C. Craddock, R. Hills, 2017 .

An operational definition of primary refractory acute myeloid leukemia allowing early identification of patients who may benefit from allogeneic stem cell transplantation

P. Vyas, C. Craddock, R. Hills, 2016, Haematologica.

Double autografting: A potential curative regimen for acute leukemia?

D. Linch, A. Goldstone, C. Anderson, 1986 .

The clinical characteristics , therapy and outcome of 85 adults with acute lymphoblastic leukemia and t ( 4 ; 11 ) ( q 21 ; q 23 ) / MLL-AFF 1 prospectively treated on UKALLXII / ECOG

M. Tallman, L. Foroni, C. Harrison, 2013 .

Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial

M. Tallman, S. Richards, A. Moorman, 2012, British journal of haematology.

(ALL); an MRC UKALL12/ECOG 2993 study Outcome of 609 adults after relapse of acute lymphoblastic leukaemia

S. Richards, R. Chopra, H. Lazarus, 2012 .

Allogeneic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia (ALL)

A. Goldstone, A. Fielding, B. Patel, 2010 .

Is There Evidence for a Graft Versus Leukemia Effect in Adult ALL ?

J. Rowe, A. Goldstone, 2009 .

Low Dose Ara-C Versus Hydroxyurea with or without Retinoid in Older Patients Not Considered Fit for Intensive Chemotherapy: The UK NCRI AML14 Trial.

M. McMullin, A. Goldstone, A. Burnett, 2004 .

Demonstration of developing myelodysplasia/acute myeloid leukaemia in haematologically normal patients after high‐dose chemotherapy and autologous bone marrow transplantation using X‐chromosome inactivation patterns

D. Linch, A. Goldstone, R. Gale, 1996, British journal of haematology.

Growth factors can protect B-chronic lymphocytic leukaemia cells against programmed cell death without stimulating proliferation.

P. Lydyard, F. Giles, A. Goldstone, 1995, Leukemia & lymphoma.

Combined T and B Cell Acute Lymphoblastic Leukaemia

J. Cawley, A. Goldstone, A. Karpas, 1974, British medical journal.

Acute lymphoblastic leukaemia (ALL) things come to those who wait: 60 years of progress in the treatment of adult ALL

A. Fielding, A. Goldstone, 2020, British journal of haematology.

Transplantations in adult acute lymphoblastic leukemia--grounds for optimism?

A. Goldstone, 2009, Clinical lymphoma & myeloma.

Transplants in Adult ALL--? Allo for everyone.

A. Goldstone, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cytomegalovirus infection and disease after autologous CD34-selected peripheral blood stem cell transplantation for multiple myeloma: no evidence of increased incidence based on polymerase-chain-reaction monitoring

S. Mackinnon, K. Peggs, A. Goldstone, 2000 .

Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working Party of the European Group for Blood and Marrow T

A. Goldstone, R. Pearce, I. Majolino, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy of delayed granulocyte colony-stimulating factor after autologous BMT.

A. Khwaja, A. Goldstone, D. Linch, 1993, Bone marrow transplantation.

The Allogeneic Effect in Non-Hodgkin's Lymphoma

A. Goldstone, P. Kottaridis, 2003, Leukemia & lymphoma.

High-Dose Therapy for the Malignant Lymphomas

A. Goldstone, W. Mills, 1995 .

T‐ and B‐cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T‐cell‐depleted, reduced‐intensity allogeneic stem cell transplantation with an alemtuzumab‐containing conditioning regimen followed by escalated donor lymphocyte infusions

S. Mackinnon, K. Peggs, S. Verfuerth, 2003, British journal of haematology.

New Evidence Relating to the Nature and Origin of the Hairy Cell of Leukaemic Reticuloendotheliosis

C. R. Barker, G. Burns, A. Goldstone, 1977, British journal of haematology.

A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter-related sepsis in patients receiving intensive chemotherapy for haematological malignancies.

A. Goldstone, S. Machin, N. Salooja, 1991, The Journal of antimicrobial chemotherapy.

Peripheral blood progenitor cells versus bone marrow.

A. Goldstone, M. Watts, A. Fielding, 1994, Journal of hematotherapy.

Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: relevance for early adoptive immunotherapy and infectious complications.

S. Mackinnon, K. Peggs, G. Hale, 2003, Blood.

Haematological recovery following high-dose cyclophosphamide with autologous bone marrow transplantation

C. Twelves, A. Goldstone, P. Harper, 2004, Cancer Chemotherapy and Pharmacology.

Molecular Classification Improves Risk Assessment in Adult BCR-ABL1-negative B-ALL.

Cheng Cheng, Chunxu Qu, O. Abdel-Wahab, 2021, Blood.

A hemalog D analysis of chronic lymphocytic leukaemia and other lymphoproliferative disorders affecting the blood.

J. Cawley, A. Goldstone, K. Patterson, 1981, Journal of clinical pathology.

Does all-transretinoic acid (ATRA) have a role in non-APL acute myeloid leukaemia?: Results from 1666 patients in three MRC trials [Abstract]

R. Hills, A. Goldstone, A. Burnett, 2004 .

FLAG is a useful regimen for poor prognosis adult myeloid leukaemias and myelodysplastic syndromes.

T. Nokes, A. Goldstone, S. Johnson, 1997, Leukemia & lymphoma.

Survival and Freedom from Progression in Autotransplant Lymphoma Patients is Independent of Stem Cell Source: Further Follow-up from the Original Randomised Study to Assess Engraftment

N. Schmitz, P. Dreger, D. Linch, 2002, Leukemia & lymphoma.

Bone Marrow Transplantation for Non-Hodgkin’s Lymphoma in Europe: The Current Position

A. Goldstone, A. McMillan, 1990 .

Granulocyte-macrophage colony-stimulating factor may inhibit neutrophil migration in vivo.

A. Goldstone, D. Linch, S. Devereux, 1989, Clinical and experimental immunology.

PHA responsiveness and subpopulations of circulating lymphocytes in pernicious anemia.

S. Urbaniak, W. Irvine, A. Goldstone, 1974, Blood.

The effect of macrophage colony‐stimulating factor on haemopoietic recovery after autologous bone marrow transplantation

A. Khwaja, D. Linch, R. Chopra, 1992, British journal of haematology.

Implications for the Use of Monoclonal Antibodies in Future Adult ALL Trials: Analysis of Antigen Expression in 505 B-Lineage (B-Lin) ALL Patients (pts) on the MRC UKALLXII/ECOG2993 Intergroup Trial.

Xiaochun Li, M. Tallman, S. Richards, 2008 .

Mini‐BEAM followed by BEAM and ABMT for very poor risk Hodgkin's disease

D. Linch, R. Chopra, A. Goldstone, 1992, British journal of haematology.

An Operational Definition of Primary Refractory Acute Myeloid Leukaemia Which Allows Early Identification of Patients for Whom Allogeneic Stem Cell Transplantation Represents the Only Curative Therapy

P. Vyas, C. Craddock, R. Hills, 2015 .

Transplantation study from the European Group for Blood and Marrow transplantation in multiple myeloma: a retrospective case-matched Allogeneic bone marrow transplantation versus autologous stem cell

R. Marcus, J. Hermans, H. Prentice, 2011 .

Atypical Surface Marker Characteristics in a T-Cell Lymphoma

R. Souhami, G. Janossy, B. Mcverry, 2009 .

Membrane marker analysis of 'lymphoid' and myeloid blast crisis in PH1 positive (chronic myeloid) leukemia.

M. Greaves, G. Janossy, A. Goldstone, 1977, Haematology and blood transfusion.

The significance of host haemopoietic cells detected by cytogenetic analysis of bone marrow from recipients of bone marrow transplants

A. Goldstone, H. Walker, J. Patterson, 1986, British journal of haematology.

Lymphocyte activation and serine-esterase induction following recombinant interleukin-2 infusion for lymphomas and acute leukaemias

F. Giles, A. Goldstone, Seah H. Lim, 2005, Cancer Immunology, Immunotherapy.

Transplants for the old but not for the young?--The enigma of adult ALL.

A. Goldstone, R. Sellar, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: limited efficacy of graft-versus-tumor activity.

S. Mackinnon, K. Peggs, G. Hale, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders.

J. Garcia-conde, C. Craddock, S. Mackinnon, 2002, Blood.

Superiority of reduced-intensity allogeneic transplantation over conventional treatment for relapse of Hodgkin's lymphoma following autologous stem cell transplantation

S. Mackinnon, K. Peggs, A. Hunter, 2008, Bone Marrow Transplantation.

Alpha interferon therapy for haematological malignancies: correlation between in vivo induction of the 2′,5′ oligoadenylate system and clinical response

F. Giles, K. Ganeshaguru, A. Hoffbrand, 1990, British journal of haematology.

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen.

C. Craddock, S. Mackinnon, K. Peggs, 2002, Blood.

Autologous bone marrow transplants: Different indications in Europe and North America

J. Armitage, A. Hagenbeek, N. Gale, 1989 .

Role of a second transplant in the management of poor-prognosis lymphomas: a report from the European Blood and Bone Marrow Registry.

L. Fouillard, A. Goldstone, R. Pearce, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Risk‐stratified adoptive cellular therapy following allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukaemia

R. Benjamin, S. Mackinnon, K. Peggs, 2013, British journal of haematology.

Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial

M. Copland, M. McMullin, A. Moorman, 2022, The Lancet. Haematology.

Recombinant Alpha 2A Interferon-An Effective Maintenance Agent in Essential Thrombocythaemia.

F. Giles, A. Mehta, A. Goldstone, 1990, Leukemia & lymphoma.

Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers

L. Chin, M. Stratton, A. Protopopov, 2007, Nature.

Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab.

C. Fegan, S. Mackinnon, G. Hale, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemias.

Dejan Juric, D. Juric, B. Sikic, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immunological parameters in the aged and in Alzheimer's disease.

J. Morris, A. N. Exton-smith, A. Goldstone, 1982, Clinical and experimental immunology.

Reply to C. Fozza.

N. Schmitz, P. Dreger, A. Goldstone, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Respiratory virus infections in transplant recipients after reduced‐intensity conditioning with Campath‐1H: high incidence but low mortality

C. Fegan, S. Mackinnon, G. Hale, 2002, British journal of haematology.

Influence of genetic predisposition to thrombosis on natural history of acute promyelocytic leukaemia

S. Langabeer, D. Grimwade, A. Goldstone, 1997, British journal of haematology.

Autologous bone marrow transplantation in multiple myeloma: a single centre experience of 23 patients.

A. Goldstone, J. Tobias, J. Richards, 1994, Leukemia & lymphoma.

New Drugs for Lung Cancer

A. Goldstone, Cancer Treat Rep, C. Trask, 2017 .

IgA and IgM cytoplastic inclusions in a series of cases of chronic lymphocytic leukaemia.

J. Cawley, A. Goldstone, J. Smith, 1976, Clinical and experimental immunology.

cytometry. IV. CD34 overexpression in acute myelogenous leukemia Leukemia-associated changes identified by quantitative flow

G. Janossy, A. Goldstone, D. Swirsky, 2011 .

Management of Non-Hodgkin’s Lymphomas in Adults in Scandinavia, the United Kingdom and the Netherlands: Conclusions of the Fourth Intercity Meeting, 1988

G. Gahrton, G. Juliusson, N. Nissen, 1990 .

Management of non-Hodgkin lymphoma in adults in Scandinavia, United Kingdom, and The Netherlands. Report from the European School of Oncology intercity meeting at Huddinge Hospital, 3rd June, 1988.

T. Lister, G. Juliusson, N. Nissen, 1989, Acta oncologica.

Idarubicin and ATRA Is as Effective as MRC Chemotherapy in Patients with Acute Promyelocytic Leukaemia with Lower Toxicity and Resource Usage: Preliminary Results of the MRC AML15 Trial.

R. Hills, N. Russell, A. Hunter, 2007 .

Electrophoresis of lymphocytes from normal human subjects and patients with chronic lymphocytic leukaemia.

S. Urbaniak, W. Irvine, A. Goldstone, 1974, Clinical and experimental immunology.

The effect of gastric antigens on the in vitro migration of leucocytes from patients with atrophic gastritis and pernicious anaemia.

E. Barnes, W. Irvine, A. Goldstone, 1973, Clinical and experimental immunology.

Hepatitis B transmission from contaminated cryopreservation tank

A. Goldstone, M. Zuckerman, N. Brink, 1995, The Lancet.

Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial

Keith Wheatley, R. Gray, A. Goldstone, 1998, The Lancet.

The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial

A. Goldstone, A. Burnett, K. Wheatley, 2002, British journal of haematology.

REMISSION INDUCTION WITH ADENOSINE-DEAMINASE INHIBITOR 2'-DEOXYCOFORMYCIN IN THY-LYMPHOBLASTIC LEUKÆMIA

G. Janossy, J. Smyth, K. Ganeshaguru, 1980, The Lancet.

Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.

R. Hills, D. Grimwade, C. Harrison, 2010, Blood.

Extended routine polymerase chain reaction surveillance and pre‐emptive antiviral therapy for cytomegalovirus after allogeneic transplantation

R. Tedder, S. Mackinnon, K. Peggs, 2000, British journal of haematology.

reconstitution cell transplantation: potential role of Campath-1H in delaying immune High incidence of cytomegalovirus infection after nonmyeloablative stem

C. Fegan, S. Mackinnon, K. Peggs, 2008 .

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution.

C. Craddock, C. Fegan, S. Mackinnon, 2002, Blood.

Myeloma in a case of hodgkin's disease.

J. Cawley, A. Goldstone, J. Arno, 1974, Acta haematologica.

Pernicious Anemia PHA Responsiveness and Subpopulations of Circulating Lymphocytes in

S. Urbaniak, W. Irvine, A. Goldstone, 2011 .

Residual T cells in chronic lymphocytic leukaemia.

S. Urbaniak, W. Irvine, A. Goldstone, 1973, Lancet.

Hepatitis B nucleotide sequence analysis: linking an outbreak of acute hepatitis B to contamination of a cryopreservation tank.

R. Tedder, A. Goldstone, M. Zuckerman, 1996, Journal of virological methods.

Recombinant Interferon-α2 Antibodies in Chronic Lymphocytic Leukemia

F. Giles, A. Goldstone, E. McSweeney, 1994 .

Recombinant interferon alfa 2 a in the treatment of patients with early stage B chronic lymphocytic leukaemia

J. Cawley, A. Mehta, A. Goldstone, 1993, British journal of haematology.

WT1 mutations in T-ALL.

A. Ferrando, R. Pieters, T. Palomero, 2009, Blood.

WT 1 mutations in TALL

A. Ferrando, R. Pieters, T. Palomero, 2009 .

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

J. Armitage, S. Jagannath, P. Biron, 1987, The New England journal of medicine.

Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocol.

A. Ferrando, M. Sulis, M. Tallman, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adolescents with acute lymphoblastic leukaemia: Outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials

S. Richards, A. Vora, J. Rowe, 2007, Pediatric blood & cancer.

Leukemia-associated changes identified by quantitative flow cytometry. IV. CD34 overexpression in acute myelogenous leukemia M2 with t(8;21).

G. Janossy, A. Goldstone, D. Swirsky, 1996, Blood.

Interferon‐alpha up‐regulates bcl‐2 expression and protects B‐CLL cells from apoptosis in vitro and in vivo

P. Lydyard, F. Giles, A. Goldstone, 1994, British journal of haematology.

Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia.

P. Freemont, D. Sheer, S. Langabeer, 1997, Blood.

HTV-2-ASSOCIATED AIDS IN THE 1970s

J. Parry, Dennis Ridley, A. Goldstone, 1988, The Lancet.

The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trial

M. Tallman, L. Foroni, G. Dewald, 2013, Haematologica.

A simple, robust, validated and highly predictive index for the determination of risk‐directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial

R. Gray, A. Goldstone, A. Burnett, 1999, British journal of haematology.

Plasma exchange in systemic lupus erythematosus.

M. Snaith, I. Roitt, A. Goldstone, 1981, Annals of the rheumatic diseases.

Plasma exchange insystemic lupus erythematosus

M. Snaith, I. Roitt, A. Goldstone, 1981 .

Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia

S. Richards, A. Vora, A. Moorman, 2004, British journal of haematology.

Ceftazidime monotherapy is as effective as ceftazidime combined with gentamicin in the treatment of febrile neutropenic patients.

A. Goldstone, S. Kinsey, S. Machin, 1990, The Journal of hospital infection.

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

D. Winfield, D. Linch, R. Chopra, 1993, The Lancet.

Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries

D. Weisenburger, J. Vose, N. Schmitz, 2003, British journal of haematology.

Production of tumour-derived suppressor factor in patients with acute myeloid leukaemia.

A. Goldstone, S. H. Lim, A. Jewell, 1991, Leukemia research.

A chronic myeloproliferative disorder associated with monosomy 7 in the bone marrow cells; normal karyotype in acute transformation

A. Goldstone, D. Linch, H. Walker, 1982, British journal of haematology.

Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia.

L. Foroni, H. Prentice, A. Goldstone, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow Transplantation.

A. Fielding, A. Goldstone, N. Milpied, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter‐related sepsis in patients receiving intensive chemotherapy for haematological malignancies

A. Goldstone, S. Machin, S. H. Lim, 1993, European journal of haematology. Supplementum.

Rituximab in combination with CODOX‐M/IVAC: a retrospective analysis of 23 cases of non‐HIV related B‐cell non‐Hodgkin lymphoma with proliferation index >95%

T. Marafioti, K. Ardeshna, I. Kayani, 2011, British journal of haematology.

Use of teicoplanin for Hickman catheter associated staphylococcal infection in immunosuppressed patients.

A. Goldstone, R. Souhami, S. J. Russell, 1987, The Journal of hospital infection.

IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia.

M. Tallman, C. Harrison, C. Schwab, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.

P. Bierman, J. Vose, N. Schmitz, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARα rearrangement in newly diagnosed AML

B. Bain, P. Freemont, S. Langabeer, 1999 .

Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. The Medical Research Council (MRC) Adult Leukaemia Working Party.

B. Bain, P. Freemont, P. Freemont, 1999, British journal of haematology.

Bone marrow transplant patients with life-threatening organ failure: when should treatment stop?

A. Goldstone, A. Perry, M. Rivlin, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Plasmapheresis in systemic lupus erythematosus.

A. Goldstone, C. Moran, J. Richards, 1977, British medical journal.

High-dose therapy and autologous bone marrow transplantation for adult patients with lymphoblastic lymphoma: results of the European Group for Bone Marrow Transplantation.

A. Goldstone, J. Sweetenham, R. Pearce, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

Dirk Hasenclever, Markus Sieber, Norbert Schmitz, 2002, The Lancet.

Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma.

N. Schmitz, B. Hillner, T. Smith, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of surgery on monocyte function.

M. Baum, A. Goldstone, K. Patterson, 1983, The British journal of surgery.

Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission

C. Craddock, N. Russell, R. Clark, 2009, Haematologica.

lymphoproliferative disorders comparison between 2 prospective studies in patients with Nonmyeloablative transplantation with or without alemtuzumab

J. Miguel, C. Craddock, D. Linch, 2013 .

NON-MYELOABLATIVE TRANSPLANTS WITH OR WITHOUT CAMPATH-1H: COMPARISON BETWEEN TWO PROSPECTIVE STUDIES IN PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS.

Dolores, J. Garcia-conde, C. Craddock, 2002 .

Treatment of aplastic anaemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (MPred) with or without androgens: a randomized trial from the EBMT SAA working party

E. Smith, A. Bosi, A. Goldstone, 1993, British journal of haematology.

Del (9q) AML: clinical and cytological characteristics and prognostic implications

L. Side, C. Harrison, J. Boultwood, 2005, British journal of haematology.

How I treat acute lymphocytic leukemia in adults.

J. Rowe, A. Goldstone, 2007, Blood.

D. Linch, R. Chopra, A. Goldstone, 1991, Leukemia & lymphoma.

Double hemibody irradiation (DHBI) in the management of relapsed and primary chemoresistant multiple myeloma.

A. Goldstone, J. Tobias, J. Richards, 1993, Clinical oncology (Royal College of Radiologists (Great Britain)).

Outcome of major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation may be influenced by conditioning regimen.

S. Mackinnon, K. Peggs, D. Linch, 2002, Blood.

Hotel-based ambulatory care for complex cancer patients: a review of the University College London Hospital experience

K. Ardeshna, S. Morris, K. Peggs, 2012, Leukemia & lymphoma.

Delayed neutrophil recovery after BEAM chemotherapy and autologous bone marrow transplantation for lymphoma is not associated with increased mortality from infection.

A. Khwaja, A. Goldstone, D. Linch, 1995, Bone marrow transplantation.

Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia.

C. Craddock, N. Russell, S. Mackinnon, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study.

Rajesh Chopra, M. Tallman, S. Richards, 2007, Blood.

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial.

A. Cherry, M. Tallman, S. Richards, 2005, Blood.

Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma.

C. Craddock, S. Mackinnon, K. Peggs, 2004, Blood.

A comparison of automated cytochemical analysis and conventional methods in the classification of acute leukaemia

G. Janossy, J. Cawley, A. Goldstone, 1980 .

The macrophage electrophoretic migration test in cancer.

W. Irvine, A. Goldstone, L. Kerr, 1973, Clinical and experimental immunology.

Prognostic factor analysis of the survival of elderly patients with AML in the MRC AML11 and LRF AML14 trials

Keith Wheatley, Anthony V Moorman, A. Moorman, 2009, British journal of haematology.

The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial

R. Hills, N. Russell, M. Dennis, 2009, British journal of haematology.

Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation.

N. Schmitz, N. Russell, S. Mackinnon, 2002, Blood.

Escalating dose donor lymphocyte infusions following non-myeloablative allogeneic transplantation are associated with minimal toxicity with sibling donors but a significant risk of severe GVHD with unrelated donors.

S. Mackinnon, D. Linch, C. Kyriacou, 2001 .

Non‐Hodgkin Lymphoma

A. Goldstone, K. Cwynarski, 2010 .

High-dose therapy for diffuse large-cell lymphoma in first remission.

A. Goldstone, A. Perry, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Antigen receptor gene rearrangements reflect on the heterogeneity of adult Acute Lymphoblastic Leukaemia (ALL) with implications of cell‐origin of ALL subgroups – a UKALLXII study

S. Richards, L. Foroni, A. Moorman, 2010, British journal of haematology.

Differential Gene Expression Patterns and Interaction Networks in BCR/ABL Positive and Negative Adult Acute Lymphoblastic Leukemias.

D. Juric, B. Sikic, P. O'dwyer, 2006 .

Cytokine induction of leucocyte adhesion molecule-1 (LAM- 1) expression on chronic lymphocytic leukaemia cells.

P. Lydyard, F. Giles, A. Goldstone, 1992, Leukemia.

Time now to TORC the TORC? New developments in mTOR pathway inhibition in lymphoid malignancies

A. Goldstone, G. Collins, T. Eyre, 2014, British journal of haematology.

Novel Approaches to the Management of Non-Hodgkin Lymphoma

A. Goldstone, T. Everington, 2005 .

Continuous intravenous infusion of high-dose recombinant interleukin-2 for acute myeloid leukaemia — a phase II study

D. Gozzard, A. Goldstone, A. Newland, 2005, Cancer Immunology, Immunotherapy.

Allogeneic haematopoietic stem cell transplant in Philadelphia-positive acute lymphoblastic leukaemia

A. Goldstone, A. Goldstone, A. Fielding, 2008, Bone Marrow Transplantation.

Serum levels of TNF, IL-6 and sCD23 correlate with changes in lymphocyte count in patients with B-cell chronic lymphocytic leukaemia receiving interferon-alpha therapy.

F. Giles, A. Goldstone, A. Jewell, 1997, Leukemia & lymphoma.

Bacterial infections in lymphoma patients treated with recombinant interleukin-2.

F. Giles, A. Goldstone, S. H. Lim, 1991, Acta haematologica.

ABC of clinical haematology: The acute leukaemias

A. Goldstone, R. Liesner, R J Liesner, 1997, BMJ.

ALPHA-INTERFERON THERAPY FOR ESSENTIAL THROMBOCYTHAEMIA

A. Mehta, F. Giles, A. Hoffbrand, 1988, The Lancet.

Prognostic factors in autologous stem cell transplantation for multiple myeloma: an EBMT Registry Study. European Group for Bone Marrow Transplantation.

P. Ljungman, A. Goldstone, M. Cavo, 1994, Leukemia & lymphoma.

Blood and Bone Marrow Transplantation analysis from the Lymphoma Working Party of the European Group for an following reduced intensity allogeneic progenitor cell transplantation: Chemoresistant or aggressive lymphoma predicts for a poor outcome

N. Schmitz, N. Russell, S. Mackinnon, 2013 .

Randomized placebo‐controlled trial of granulocyte colony stimulating factor (G‐CSF) as supportive care after induction chemotherapy in adult patients with acute myeloid leukaemia: a study of the United Kingdom Medical Research Council Adult Leukaemia Working Party

A. Goldstone, A. Burnett, K. Wheatley, 2009, British journal of haematology.

Autologous Stem Cell Transplantation Using BEAM Conditioning Is Highly Effective in Patients with Follicular Lymphoma Regardless of Prior Rituximab Exposure

K. Ardeshna, K. Peggs, D. Linch, 2011 .

Modern trends in bone marrow transplantation for acute myeloid and acute lymphoblastic leukemia

R. Chopra, A. Goldstone, 1992, Current opinion in oncology.

High-dose therapy and autologous bone marrow transplantation for intermediate and high grade non-Hodgkin's lymphoma in patients aged 55 years and over: results from the European Group for Bone Marrow Transplantation. The EBMT Lymphoma Working Party.

F. Mandelli, P. Colombat, A. Goldstone, 1994, Bone marrow transplantation.

Comparison of peripheral blood stem-cell and autologous bone marrow transplantation for lymphoma patients: a case-controlled analysis of the EBMT Registry data. Lymphoma Working Party of the EBMT.

A. Goldstone, R. Pearce, I. Majolino, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Myeloma in mother and daughter.

A. Goldstone, J. Wood, M. Cook, 1973, Acta haematologica.

The addition of gemtuzumab ozogamicin to induction chemotherapy for AML improves disease free survival without extra toxicity: Preliminary analysis of 1115 patients in the MRC AML15 trial.

R. Hills, N. Russell, A. Hunter, 2006 .

High-dose therapy and autologous bone marrow transplantation in first complete remission for adult patients with high-grade non-Hodgkin's lymphoma: the EBMT experience. Lymphoma Working Party of the European Group for Bone Marrow Transplantation.

D. Blaise, A. Goldstone, J. Sweetenham, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Use of 18F‐FDG positron emission tomography following allogeneic transplantation to guide adoptive immunotherapy with donor lymphocyte infusions

S. Mackinnon, K. Peggs, P. Ell, 2005, British journal of haematology.

HLA antigens in pernicious anaemia.

J. Cawley, W. Irvine, A. Goldstone, 1976, Clinical and experimental immunology.

Automated leucocyte differential counts in chronic lymphocytic and hairy-cell leukaemias: a comparison of the Hemalog D, H6000 and Coulter S Plus IV.

A. P. Lai, J. Cawley, A. Goldstone, 1987, Clinical and laboratory haematology.

Growth Factor Administration in Lymphoma Transplants: Use of Flow Cytochemistry via the H*1 in Predictin Engraftment

A. Goldstone, A. Khwaja, Tsakona Cp, 1992 .

Ring chromosome 6 and i(17q-) in a patient with acute promyelocytic leukemia. Absence of translocation t(15;17).

A. Goldstone, H. Walker, S. J. Russell, 1988, Cancer genetics and cytogenetics.

Scientific program and abstractDouble autografting: A potential curative regimen for acute leukemia?

D. Linch, A. Goldstone, C. Anderson, 1986 .

Cellular cytotoxic function and potential in acute myelogenous leukaemia.

A. Goldstone, S. H. Lim, A. Jewell, 1991, Leukemia research.

Long-term follow-up of an alemtuzumab (CAMPATH-1H) containing reduced intensity allogeneic transplant regimen for non-Hodgkin's lymphoma (NHL).

C. Craddock, S. Mackinnon, K. Peggs, 2002 .

Does Imatinib Change the Outcome in Philapdelphia Chromosome Positive Acute Lymphoblastic Leukaemia in Adults? Data from the UKALLXII/ECOG2993 Study.

M. Tallman, S. Richards, H. Lazarus, 2007 .

Acute Lymphoblastic Leukemia: Epidemiology

A. Goldstone, M. Hourigan, 2011 .

Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning

M. Singer, S. Mackinnon, K. Peggs, 2013, British journal of haematology.

Lymphocyte activation in patients with acute myeloid leukaemia Evidence for the presence of myeloblast antigen?

A. Goldstone, Seah H. Lim, C. Worman, 2005, Cancer Immunology, Immunotherapy.

Chronic lymphocytic leukaemia uncovered by successful treatment of acute myeloid leukaemia.

G. Janossy, A. Goldstone, R. Warwick, 1976, British medical journal.

STUDIES OF CELL SIZE IN LYMPHOPROLIFERATIVE DISORDERS

A. Goldstone, J. Richards, K. Patterson, 1980 .

TEL‐AML1 fusion in acute lymphoblastic leukaemia of adults

R. Aguiar, J. Goldman, N. Cross, 1996, British journal of haematology.

Incidence of AML1/ETO fusion transcripts in patients entered into the MRC AML trials

D C Linch, K Wheatley, S. Langabeer, 1997, British journal of haematology.

Frequency of CBFβ/MYH11 fusion transcripts in patients entered into the U.K. MRC AML trials

S. Langabeer, D. Linch, A. Goldstone, 1997 .

Patients with Lymphoplasmacytic Lymphoma Can Be Salvaged with Autologous Stem Cell Transplantation, Irrespectively of the Number of Previous Treatment Lines. Analysis of 146 Cases from the European Bone Marrow Transplant Registry (EBMT).

N. Schmitz, D. Linch, C. Kyriakou, 2004 .

Distinctive cytoplasmic inclusions in chronic lymphocytic leukaemia.

J. Cawley, T. Hamblin, D. Hough, 1975, European Journal of Cancer.

Imatinib Significantly Enhances Long Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia, Final Results of the UKALLXII/ECOG2993 Trial

M. Tallman, S. Richards, A. Moorman, 2010 .

Recombinant alpha-interferons, thyroid irradiation and thyroid disease.

A. Goldstone, A. Jewell, F. Giles, 1991, Acta haematologica.

Acute promyelocytic leukaemia

A. Goldstone, S. Machin, A. Fielding, 1994, The Lancet.

Influence of computer-aided detection false-positives on reader performance and diagnostic confidence for CT colonography.

Damian Tolan, Steve Halligan, Paul Bassett, 2009, AJR. American journal of roentgenology.

High-dose therapy with hematopoietic transplantation for Hodgkin's lymphoma.

A. Laurence, A. Goldstone, 1999, Seminars in hematology.

Letter: Autoimmune haemolytic anaemia in ulcerative colitis.

A. Goldstone, 1974, British medical journal.

Autologous stem cell transplantation for T and null cell CD30-positive anaplastic large cell lymphoma: analysis of 64 adult and paediatric cases reported to the European Group for Blood and Marrow Transplantation (EBMT)

R. Fanin, M. Baccarani, A. Goldstone, 1999, Bone Marrow Transplantation.

G‐CSF after peripheral blood stem cell transplantation in lymphoma patients significantly accelerated neutrophil recovery and shortened time in hospital: results of a randomized BNLI trial

D. Winfield, D. Linch, A. Fielding, 1997, British journal of haematology.

A second autologous transplant may be efficacious in selected patients with Hodgkin's lymphoma relapsing after a previous autograft

K. Peggs, D. Linch, A. Goldstone, 2007, Leukemia & lymphoma.

Standard Consolidation/Maintenance Chemotherapy Is Consistently Superior to a Single Autologous Transplant for Adult Patients with Acute Lymphoblastic Leukemia: Results of the International ALL Trial (MRC UKALL XII/ECOG E2993)

M. Tallman, S. Richards, G. Dewald, 2008 .

Leukostasis in chronic myeloid leukaemia.

A. Goldstone, D. Thompson, J. Richards, 1978, British medical journal.

Low‐dose thalidomide in combination with oral weekly cyclophosphamide and pulsed dexamethasone is a well tolerated and effective regimen in patients with relapsed and refractory multiple myeloma

C. Kyriakou, A. Goldstone, K. Yong, 2005, British journal of haematology.

High-dose cyclophosphamide with autologous marrow transplantation for small cell carcinoma of the bronchus

R. Souhami, D. Geddes, D. Linch, 2004, Cancer Chemotherapy and Pharmacology.

Delays in postremission chemotherapy for Philadelphia chromosome negative acute lymphoblastic leukemia are associated with inferior outcomes in patients who undergo allogeneic transplant: An analysis from ECOG 2993/MRC UK ALLXII

P. Gimotty, M. Tallman, J. Gelfand, 2016, American journal of hematology.

Serum macrophage colony‐stimulating factor (M‐CSF) levels correlate with clinical response to interferon‐alpha in patients with early‐stage B‐CLL

A. Goldstone, A. Jewell, K. Yong, 1994, British journal of haematology.

Clonal identification in acute lymphoblastic leukemia.

G. Janossy, B. Mcverry, A. Goldstone, 1979, Blood.

Outcome of 1,229 Adult Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia (B-ALL) Patients (pts) From the International UKALLXII/E2993 Trial: No Difference In Results Between B Cell Immunophenotypic Subgroups

M. Tallman, S. Richards, G. Dewald, 2010 .

At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial

C. Mullighan, C. Willman, M. Tallman, 2020, British journal of haematology.

Platelet hyperaggregability occurring during prolonged continuous intravenous infusions of prostacyclin analogue ZK 36374

A. Goldstone, I. Mackie, S. Machin, 1985, British journal of haematology.

Long-term follow-up of an alemtuzumab (CAMPATH-1H)-containing reduced intensity allogeneic transplant (RIT) regimen for relapsed and refractory non-Hodgkin's lymphoma (NHL)

C. Craddock, S. Mackinnon, K. Peggs, 2004 .

Neurological complications following alemtuzumab-based reduced-intensity allogeneic transplantation

S. Mackinnon, D. Linch, A. Dogan, 2004, Bone Marrow Transplantation.

Long-term results of the MRC AML10 trial.

R. Hills, A. Goldstone, A. Burnett, 2006, Clinical advances in hematology & oncology : H&O.

Systemic Irradiation Therapy of Myelomatosis-The Therapeutic Implications of Technique.

A. Goldstone, A. Newland, J. Tobias, 1990, Leukemia and Lymphoma.

T-Cell Depleted Unrelated Donor Stem Cell Transplants Appear to Be of Value for Adult Philadelphia Chromosome Negative ALL Patients and Should Be Evaluated Prospectively in New Large Group Studies

C. Craddock, N. Russell, R. Clark, 2008 .

Folic acid and the pill.

A. Goldstone, J. Wood, N. Allan, 2009, Scandinavian Journal of Haematology.

Prophylactic teicoplanin during insertion of Hickman catheters

A. Goldstone, S. Machin, S. H. Lim, 1990, British journal of haematology.

Teicoplanin and prophylaxis of Hickman catheter insertions.

A. Goldstone, S. Machin, S. H. Lim, 1992, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement.

Adult patients with acute lymphoblastic leukemia (ALL) and central nervous system (CNS) leukemia at diagnosis may attain durable complete remissions (CR). Results from the international ALL trial (MRC UKALL-XII/ECOG E2993)

M. Tallman, S. Richards, R. Chopra, 2004 .

The outcome of 551 1(st) CR transplants in adult ALL from the UKALL XII/ECOG 2993 study

M. Tallman, S. Richards, R. Chopra, 2004 .

Bone Marrow Transplantation Versus Chemotherapy in Acute Lymphoblastic Leukemia. Joint Trial of the Medical Research Council (UKALL-12) with the United States Eastern Cooperative Oncology Group E2993

S. Richards, H. Lazarus, J. Rowe, 1997 .

Rituximab Does Not Increase the Complication Rate, Particularly Perforation, When Added to Chemotherapy for Patients with Primary B-Cell Lymphomas of the Gastrointestinal Tract.

A. Goldstone, D. Hughes, A. Prentice, 2005 .

Tallman, P. Gimotty, J. Gelfand, 2017, American journal of hematology.

DURABLE BENEFIT OF RITUXIMAB MAINTENANCE POST‐AUTOGRAFT IN PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA: 12‐YEAR FOLLOW‐UP OF THE EBMT LYMPHOMA WORKING PARTY LYM1 TRIAL

E. Kimby, N. Schmitz, S. Montoto, 2017 .

Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993.

M. Tallman, S. Richards, R. Chopra, 2006, Blood.

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.

K Wheatley, D. Grimwade, C. Harrison, 1998, Blood.

L. Staudt, D. Weisenburger, J. Vose, 2008 .

Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the Medical Research Council.

R. Gray, R. Gray, A. Goldstone, 1997, Blood.

Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients; analysis of the UK Medical Research Council AML 10 Trial.

M. Watson, A. Goldstone, A. Burnett, 2004, European journal of cancer.

Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study

N. Schmitz, S. Montoto, T. A. Lister, 2007, Leukemia.

Acute Promyelocytic Leukemia Characterization of Cryptic Rearrangements and Variant Translocations in

D. Sheer, S. Langabeer, P. Gorman, 2013 .

In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation.

G. Morgan, S. Mackinnon, K. Peggs, 2000, Blood.

The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage.

A. Goldstone, A. Goldstone, S. Bradley, 1999, The Journal of antimicrobial chemotherapy.

Autologous bone marrow transplantation for pediatric Hodgkin's disease: a case-matched comparison with adult patients by the European Bone Marrow Transplant Group Lymphoma Registry.

J. Armitage, G. Meloni, A. Goldstone, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial.

R. Clark, A. Goldstone, A. Burnett, 2001, Blood.

Successful treatment of acute myeloid leukemia beyond first remission with autologous bone marrow transplantation using busulfan/cyclophosphamide and unpurged marrow: the British autograft group experience.

R. Marcus, H. Prentice, R. Chopra, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Autologous bone marrow transplantation following high dose chemotherapy for the treatment of adult patients with acute myeloid leukaemia

D. Linch, A. Goldstone, D. Linch, 1986, British journal of haematology.

High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingd

N. Schmitz, S. Kvaløy, H. Holte, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): cytogenetic features, clinical characteristics and outcome

M. Tallman, C. Harrison, A. Moorman, 2014, Leukemia.

Factor Vila and other Haemostatic Variables following Bone Marrow Transplantation

R. Chopra, A. Goldstone, P. Collins, 1994, Thrombosis and Haemostasis.

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial.

D. Grimwade, C. Harrison, A. Goldstone, 2001, Blood.

The role of haemopoietic growth factors in bone marrow transplantation.

A. Khwaja, A. Goldstone, A. Goldstone, 1990, Leukemia research.

Scabies Infestation following Autologous Bone Marrow Transplantation.

P. Vyas, A. Goldstone, S. Kinsey, 1990, Leukemia and Lymphoma.

T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL

A. Ferrando, M. Tallman, S. Richards, 2009 .

Refinement of cytogenetic classification in acute myeloid leukaemia: Determination of prognostic significance of rarer recurring chromosomal abnormalities amongst 5,876 younger adult patients treated in the UK Medical Research Council trials

R. Hills, D. Grimwade, C. Harrison, 2010 .

Low-dose recombinant alfa-2a-interferon: a feasible maintenance therapy in acute myeloid leukaemia in the older patient.

A. Goldstone, A. Burnett, D. Milligan, 1993, Acta haematologica.

R. Hills, D. Grimwade, C. Harrison, 2010, Blood.

Time now to TORC the TORC? New developments in mTOR pathway inhibition in lymphoid malignancies

A. Goldstone, G. Collins, T. Eyre, 2014, British journal of haematology.

Clinical Trials and Observations

Rajiv Chopra, H. Lazarus, E. Paietta, 2022 .

Risk‐stratified adoptive cellular therapy following allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukaemia

R. Benjamin, S. Mackinnon, K. Peggs, 2013, British journal of haematology.

UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia.

M. Tallman, L. Foroni, G. Gerrard, 2014, Blood.

UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia